view more →
Bivarus is a healthcare IT company that has developed an elegant and efficient patient survey platform. Acquired by Press Ganey Associates in January 2018.
view more →
(BITT) is a Boston-based biopharmaceutical company developing immune-based approaches for the treatment of cancer and infectious diseases.
view more →
Developer of a technology designed to extract highly sensitive nucleic acid quantification. Acquired by Bio-Rad 2021
view more →
Provider of a clinical research platform intended to revolutionize the clinical research industry
view more →
Kymera is developing a heterobifunctional small molecule drug platform. IPO in August 2020 (NASDAQ: KYMR).
view more →
Provider of patient experience platform designed to facilitate the relationship between physicians and patients. Acquired by NextGen 2019
view more →
Developer of staffing, communication and schedule management tools designed to modernize staffing processes. Acquired by HealthStream 2020
view more →
Perfuse Therapeutics, Inc. is a seed stage biotechnology company focusing on improving retinal perfusion
view more →
Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology.
view more →
A developer of multiple antibiotic drugs intended to combat antimicrobial resistance. Acquired by Shionogi 2023
view more →
The SHAPE-MaP technology developed in the lab of Dr. Weeks identifies functional motifs within RNA by mapping the RNA three-dimensional structure.
view more →
Developer of epigenetic drugs intended to be used for the treatment of cognitive disorders and diseases of the brain. Acquired by NASDAQ: ALKS in Nov 2019
view more →
Standard Bariatrics is developing a clamp and stapler to standardize sleeve gastrectomy procedures. Acquired by Teleflex in September 2022.
view more →
Stridebio is developing engineered viral vectors for gene therapy. Acquired by Ginkgo Bioworks 2023
view more →
Developer of novel engineered compounds designed to corneal dystrophies, improve human health and create new therapies using drugs developed with protein engineering.
